Montes Kevin, Atluri Himachandana, Silvestre Tuch Hibeb, Ramirez Lucrecia, Paiz Juan, Hesse Lopez Ana, Bailey Thomas C, Spec Andrej, Mejia-Chew Carlos
Department of Medicine, Washington University School of Medicine in St. Louis, USA.
Tuberculosis Program, Ministry of Public Health and Social Assistance, Guatemala City, Guatemala.
J Clin Tuberc Other Mycobact Dis. 2021 Nov 15;25:100287. doi: 10.1016/j.jctube.2021.100287. eCollection 2021 Dec.
Risk factors for mortality and MDR-TB in Guatemala are poorly understood. We aimed to identify risk factors to assist in targeting public health interventions.
We performed a retrospective study of adults with pulmonary TB reported to the Guatemalan TB Program between January 1, 2016 and December 31, 2017. The primary objective was to determine risk factors for mortality in pulmonary TB. The secondary objective was to determine risk factors associated with MDR-TB.
Among 3,945 patients with pulmonary TB, median age was 39 years (IQR 25-54), 59% were male, 25% of indigenous ethnicity, 1.1% had MDR-TB and 3.9% died. On multivariable analysis, previous TB treatment (odds ratio [OR] 3.57, CI 2.24-5.68 [p < 0.001]), living with HIV (OR 3.98, CI 2.4-6.17 [p < 0.001]), unknown HIV diagnosis (OR 2.65, CI 1.68-4.18 [p < 0.001]), indigenous ethnicity (OR 1.79, CI 1.18-2.7 [p = 0.005]), malnutrition (OR 7.33, CI 3.24-16.59 [p < 0.001]), and lower educational attainment (OR 2.86, CI 1.43-5.88 [p = 0.003]) were associated with mortality. Prior treatment (OR 53.76, CI 25.04-115.43 [p < 0.001]), diabetes (OR 4.13, CI 2.04-8.35 [p < 0.001]), and indigenous ethnicity (OR 11.83, CI 1.46-95.73 [p = 0.02]) were associated with MDR-TB.
In Guatemala, both previous TB treatment and indigenous ethnicity were associated with higher TB mortality and MDR-TB risk among patients with pulmonary TB.
危地马拉结核病死亡率和耐多药结核病的风险因素尚不清楚。我们旨在确定风险因素,以协助确定公共卫生干预措施的目标人群。
我们对2016年1月1日至2017年12月31日期间向危地马拉结核病项目报告的成年肺结核患者进行了一项回顾性研究。主要目标是确定肺结核死亡率的风险因素。次要目标是确定与耐多药结核病相关的风险因素。
在3945例肺结核患者中,中位年龄为39岁(四分位间距25 - 54岁),59%为男性,25%为原住民,1.1%患有耐多药结核病,3.9%死亡。多变量分析显示,既往结核病治疗史(比值比[OR] 3.57,可信区间[CI] 2.24 - 5.68 [p < 0.001])、感染艾滋病毒(OR 3.98,CI 2.4 - 6.17 [p < 0.001])、艾滋病毒诊断情况不明(OR 2.65,CI 1.68 - 4.18 [p < 0.001])、原住民身份(OR 1.79,CI 1.18 - 2.7 [p = 0.005])、营养不良(OR 7.33,CI 3.24 - 16.59 [p < 0.001])以及较低的教育程度(OR 2.86,CI 1.43 - 5.88 [p = 0.003])与死亡率相关。既往治疗史(OR 53.76,CI 25.04 - 115.43 [p < 0.001])、糖尿病(OR 4.13,CI 2.04 - 8.35 [p < 0.001])以及原住民身份(OR 11.83,CI 1.46 - 95.73 [p = 0.02])与耐多药结核病相关。
在危地马拉,既往结核病治疗史和原住民身份与肺结核患者较高的结核病死亡率和耐多药结核病风险相关。